Introduction Nintedanib and pirfenidone reduce the rate of progression in fibrotic lung diseases. Until 2024 these medications could only be prescribed by tertiary specialist centres in England. We ...

Background Malignant pleural effusion (MPE) causes debilitating breathlessness and predicting survival is challenging. This study aimed to obtain contemporary data on survival by underlying tumour ...

Correspondence to Dr Andrew Tai, Dept of Respiratory and Sleep Medicine, Women's and Children's Hospital, 72 King William Road, North Adelaide, Adelaide, South Australia 5006, Australia; andrew.tai{at ...

1 Department of Pulmonary Medicine, Medisch Spectrum Twente, Enschede, The Netherlands 2 Department of Pulmonary Medicine, University Medical Centre Nijmegen, The Netherlands Background: The idea of ...

Correspondence to Professor David R Baldwin, Nottingham University Hospitals and University of Nottingham, David Evans Research Centre, Nottingham City Hospital Campus, Nottingham NG5 1PB, UK; ...

Respiratory Investigation Unit, Department of Medicine, Queen’s University, Kingston, Ontario, Canada Dr Denis E O’Donnell, Respiratory Investigation Unit, Department of Medicine, Queen’s University, ...

The Efficacy and Safety of Triple Therapy in Obstructive Lung Disease (ETHOS) and Informing the Pathway of Chronic ...

Introduction and Objectives Several studies have described the typical imaging features of empyema on CT, including pleural thickening, pleural enhancement, septation and loculation. However, there ...

A 72-year-old woman presented with a 6-month history of productive cough, hoarseness and exertional dyspnoea. She is a ...